Mental Health Clinics in Walnut, CA Accepting Medicare
8 Mental Health Clinics found. Showing 1 - 8
 Alberto & Brittany Analysis Aba Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 382 N Lemon Ave Apt 477, Walnut, CA 91789 Phone: 909-262-3484 |
New Chance Rehab Llc Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 3990 Valley Blvd Ste A, Walnut, CA 91789 Phone: 626-533-3309 |
Onpoint Behavior Consulting Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 340 S Lemon Ave # 5675, Walnut, CA 91789 Phone: 925-226-8976 |
Alma Family Services Walnut Op Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 18780 Amar Rd, Suite 204, Walnut, CA 91789 Phone: 626-965-4463 Fax: 626-965-9240 |
The Filipina Social Worker Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 465 Los Gatos Dr, Walnut, CA 91789 Phone: 909-274-0726 |
Cerebrate, A Licensed Clinical Social Worker Professional Corporation Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 20651 Golden Springs Dr Ste F3024, Walnut, CA 91789 Phone: 818-900-4027 |
Ak Behavior Analysts Llc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 21615 Brookside Ct, Walnut, CA 91789 Phone: 909-569-5814 |
Wisdom Wellness Psychotherapy Inc Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 340 S. Lemon Ave #4028, Walnut, CA 91789 Phone: 916-546-5228 |
News Archive
Findings highlight possible new approach to combat malaria
An international team of scientists, including researchers at Columbia University Medical Center, has identified a key metabolic enzyme that common malaria parasites require for survival at each stage of infection in humans. The findings raise the possibility of a new approach to combating malaria, one of the world's deadliest diseases. The study was published today in the online edition of the journal Nature.
Genzyme, Isis present mipomersen phase 3 study data in severe heFH at ACC meeting
Genzyme Corp., a subsidiary of sanofi-aventis Group, and Isis Pharmaceuticals Inc. announced today that data from two phase 3 studies of mipomersen in patients who had high cholesterol levels while on lipid-lowering therapy were presented at the American College of Cardiology's 60th Annual Scientific Session.
Favorable preliminary results from XenoPort's XP23829 Phase 1 trial on RRMS, psoriasis
XenoPort, Inc. announced today favorable preliminary results from a Phase 1 clinical trial in healthy adults designed to assess the pharmacokinetics (PK), safety and tolerability of single doses of four different oral formulations of XP23829, a novel fumaric acid ester compound that is a prodrug of monomethyl fumarate (MMF).
KHN column: The Roadmap lives
In his latest Kaiser Health News column, James Capretta writes: "Last year, Rep. Paul Ryan's 'Roadmap' - his far-reaching plan to restore long-term budget balance through tax and entitlement reform - was the subject of relentless attacks by those favoring a larger government role in American life. New York Times columnist Paul Krugman called Ryan the 'Flimflam Man' in a widely cited opinion piece in which he tried to dismiss the Roadmap as not a credible solution to the nation's budget problems.
› Verified 5 days ago